Related Experiment Video

Updated: Jul 7, 2026

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

Proteomic analysis in cardiovascular diseases

C Cieniewski-Bernard1, A Acosta, E Dubois

  • 1National Institute of Health and Medical Research (INSERM, Unit 744), Lille, France.

Clinical and Experimental Pharmacology & Physiology
|March 1, 2008
PubMed

Insights

Understanding cardiovascular diseases requires advanced proteomic analysis. This study uses differential proteomics and bioinformatics to identify novel biomarkers for heart dysfunction, improving disease mechanism insights.

Area of Science:

  • Cardiovascular research
  • Proteomics
  • Molecular biology

Background:

  • Cardiovascular diseases are a leading cause of death globally.
  • The molecular mechanisms underlying heart dysfunction remain largely unknown.
  • Gene complexity, including alternative splicing and post-translational modifications, leads to diverse protein products from a single gene.

Purpose of the Study:

  • To investigate the molecular mechanisms of cardiovascular diseases.
  • To identify novel biochemical factors and biomarkers associated with heart dysfunction.
  • To enhance the understanding of integrated biochemical responses in cardiovascular pathology.

Main Methods:

  • Utilizing differential proteomics to analyze protein expression levels.
  • Employing techniques such as two-dimensional electrophoresis (2D-gel) and Surface-Enhanced Laser Desorption/Ionization Time of Flight (SELDI-TOF).
  • Integrating mass spectrometry and bioinformatic tools for protein profile comparison across biological samples.

Main Results:

  • Proteomic analysis provides a comprehensive view of protein expression changes.
  • Differential proteomics reveals integrated biochemical responses.
  • Bioinformatic tools enable effective comparison of protein profiles from various samples.

Conclusions:

  • The combined proteomic and bioinformatic approaches are valuable for studying cardiovascular diseases.
  • This methodology aids in elucidating disease mechanisms.
  • New biochemical factors and biomarkers for cardiovascular diseases can be identified.

More Related Videos

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease08:51

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease

Published on: September 20, 2024

Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery05:30

Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery

Published on: January 31, 2025

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...